Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Article | IMSEAR | ID: sea-192175

ABSTRACT

Eruption of first primary teeth is the most anxiously awaited developmental milestone in a child. However, primary teeth have shown wide variations in their eruption time among different population, ethnic, and racial groups. Aims: The present study was conducted with the aim to evaluate the time and sequence of eruption of primary teeth of children of Mysore. Settings and Design: A cross-sectional study design included 1392 participants aged 3 months to 36 months recruited by simple random sampling method. The variables such as age, gender, and number of erupted primary teeth were recorded. Subjects and Methods: Clinical examination was done under natural illumination. A tooth was considered erupted when any part of its crown had penetrated the gingiva and was visible in the oral cavity. Statistical Analysis Used: Probit regression analysis was performed to obtain the mean and median age of eruption of teeth. The significance of difference in the mean age of eruption across gender and arch was determined using paired t-test. Results and Conclusion: The first primary tooth to erupt was mandibular central incisor at 10.24 ± 2.47 months followed by maxillary central incisor at 11.06 ± 2.65 months. The duration of primary teeth eruption was 17.89 and 18.32 months in males, 18.54 months and 18.32 months in females for maxilla and mandible, respectively. Eruption of primary tooth is delayed among children of Mysore as compared to standard eruption chart. The results will provide information to health professional about contemporary tooth eruption time derived from an Indian population.

2.
Indian Pediatr ; 2013 August; 50(8): 783-785
Article in English | IMSEAR | ID: sea-169933
3.
Indian Pediatr ; 2012 September; 49(9): 755-756
Article in English | IMSEAR | ID: sea-169469

ABSTRACT

This school based cross sectional study was done to estimate the prevalence of prehypertension and hypertension among apparently healthy school children in urban and rural Mysore. Prevalence of prehypertension and hypertension was 2.9% and 2.8% in urban children and 2.8% and 2% in rural children with no statistically significant difference between them.

4.
Indian Pediatr ; 2011 Apr; 48(4): 295-299
Article in English | IMSEAR | ID: sea-168810

ABSTRACT

school children in Mysore city. Design: Cross sectional study. Settings: Children aged 5-10 years from three schools in Mysore city were included. Study was done over a period of 1 year during 2006-2007. Participants: 726 children (59.8% males). Main Outcome: Prevalence of prediabetes. Prediabetes was defined as fasting blood sugar level between 100-125 mg/dL. Results: The prevalence of prediabetes was 3.7%. No statistically significant association was observed with major risk factors of diabetes. Conclusions: Efforts must be made to recognize type 2 diabetes in the asymptomatic prediabetes state.

5.
Indian Pediatr ; 2010 Feb; 47(2): 171-173
Article in English | IMSEAR | ID: sea-168409

ABSTRACT

We conducted this study to document the prevalence of obesity, overweight and underweight in the school children aged 5 to 16 years from Mysore. 5 Principal Investigators and 13 Co-Investigators trained the teachers of 139 schools (Private -111, Govt-28) to record the vital statistics of the children studying in their schools. A total of 43152 school children (23527 boys and 19625 girls) were surveyed. 36354 children were from private schools and 6798 children were from Government (Govt) schools. Indian Academy of Pediatrics growth charts were used as reference. The prevalence of obesity, overweight and underweight were 3.4%, 8.5% and 17.2%, respectively. The prevalence of obesity was maximum in the age group of 5-7 years and in those from private schools.

6.
Indian J Pediatr ; 2009 June; 76(6): 660
Article in English | IMSEAR | ID: sea-142315
7.
Indian J Pediatr ; 2008 Jul; 75(7): 709-13
Article in English | IMSEAR | ID: sea-79076

ABSTRACT

OBJECTIVE: To evaluate the efficacy and safety of Bifilac on reducing the episodes (frequency) and duration of diarrhea induced by rotaviral infection and to evaluate the efficacy of Bifilac to ameliorate the associated symptoms like dehydration and duration of rotaviral shedding in faeces. METHODS: 80 children aged between 3 months and 3 years were enrolled and divided into 2 groups, one group received standard therapy + placebo, the other group received standard therapy + probiotic (Bifilac) randomly. Children assessed for frequency and duration of diarrhea. Degree of dehydration, duration and volume of oral rehydration salt [ORS] therapy, duration and volume of Intra venous fluids and duration of rotaviral shedding. RESULTS: When compared to the placebo, Bifilac showed clinical as well as statistically significant reduction in Number of episodes (frequency) of diarrhea in a day, mean duration of diarrhea (in days) degree of dehydration, duration and volume of oral rehydration salt [ORS] therapy, duration and volume of intravenous fluid [IVF] therapy, duration of rotaviral shedding (P<0.01). CONCLUSION: The synbiotic, bifilac, appears to be a safe and very effective adjuvant in the management of acute rotaviral diarrhea.


Subject(s)
Acute Disease , Anti-Infective Agents/therapeutic use , Child, Preschool , Dehydration/drug therapy , Diarrhea/drug therapy , Double-Blind Method , Drug Combinations , Female , Fluid Therapy , Humans , Infant , Male , Muramidase/therapeutic use , Probiotics/therapeutic use , Rehydration Solutions/therapeutic use , Rotavirus/isolation & purification , Rotavirus Infections/drug therapy , Treatment Outcome , Virus Shedding
8.
Indian J Hum Genet ; 2006 Jan; 12(1): 11-16
Article in English | IMSEAR | ID: sea-143292

ABSTRACT

Background: Prevalence studies on Congenital heart Diseases (CHDs) have been done several times world wide and such studies are very limited in Indian populations. A few earlier studies in India have reported an increased prevalence of CHDs ranging from 2.25 to 50.89 per 1000 live births. Aims and Objective: To study the prevalence of congenital heart diseases in Indian population. Materials and Methods: Data on the prevalence of CHDs were collected and analyzed from the three major hospitals of Mysore, Cheluvamba Hospital, CSI Holdsworth Memorial Hospital and J.S.S Hospital from the year 2000 to 2004. Results: The prevalence of CHDs for five years in Mysore hospitals ranges from 6.6 to 13.06 per 1000 live births. The most frequent type of CHD was found to be VSD (40.47%) followed by ASD (19.06%), TOF (13.38%) and PDA (9.53%). It is clear that the maximum CHDs were detected in the first year of life when compared to the later years of life. The prevalence of CHDs in Mysore is increasing from 2000 to 2004 which might be due to the improvement of diagnosis, attention or awareness among the medical authorities on the disease. Conclusion: The prevalence of CHDs in Mysore is not very high as reported in other parts of the country, however; it is an important disease which needs an immediate medical attention.

9.
Indian J Pediatr ; 2002 May; 69(5): 385-8
Article in English | IMSEAR | ID: sea-81057

ABSTRACT

OBJECTIVE: This study was aimed to evaluate the usage patterns of aminoglycosides in pediatric patients for their appropriateness. METHODS: A retrospective review was conducted over a period of six months at J.S.S. Hospital, Mysore. Patients who received parenteral aminoglycosides and below the age of 12 years were included in this study. RESULTS: A total of 197 pediatric patients were evaluated for the appropriateness and was found to be 72%, 86%, 85%, 43% & 53% for indication, dose, duration, safety and cost effectiveness respectively. Majority of the patients were treated with gentamicin (53%). The most frequent indication was respiratory tract infections (50%). CONCLUSION: Effort was made to encourage judicious and quality use of aminoglycosides among the pediatricians of J.S.S. Hospital to ensure better patient care by implementation of the aminoglycosides guidelines.


Subject(s)
Amikacin/therapeutic use , Anti-Bacterial Agents/economics , Child , Child, Preschool , Cost-Benefit Analysis , Drug Utilization Review , Female , Gentamicins/therapeutic use , Humans , India , Infant , Infant, Newborn , Male , Medical Audit , Pediatrics/standards , Practice Patterns, Physicians'/statistics & numerical data , Practice Guidelines as Topic , Retrospective Studies , Streptomycin/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL